Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Sudeep Tanwar; Paul M Trembling; Brian J Hogan; Ankur Srivastava; Julie Parkes; Scott Harris; Paul Grant; Eleni Nastouli; Mathias Ocker; Klaus Wehr; Christoph Herold; Daniel Neureiter; Detlef Schuppan; William M Rosenberg

doi:10.1097/MEG.0000000000000789

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Sudeep Tanwar
, Paul M Trembling
, Brian J Hogan
, Ankur Srivastava
, Julie Parkes
, Scott Harris
, Paul Grant
, Eleni Nastouli
, Mathias Ocker
, Klaus Wehr
, Christoph Herold
, Daniel Neureiter (Co-author)
, Detlef Schuppan
, William M Rosenberg

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

12 Citations (Web of Science)

Original language	English
Pages (from-to)	289-296
Journal	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Volume	29
Issue number	3
DOIs	https://doi.org/10.1097/MEG.0000000000000789
Publication status	Published - 2017

Keywords

CHRONIC HEPATITIS-C
VALIDATED PREDICTOR
UNITED-STATES
INFECTION
TESTS
ELASTOGRAPHY
CIRRHOSIS
ACCURACY
BIOPSY

Access to Document

10.1097/MEG.0000000000000789

Cite this

Tanwar, S., Trembling, P. M., Hogan, B. J., Srivastava, A., Parkes, J., Harris, S., Grant, P., Nastouli, E., Ocker, M., Wehr, K., Herold, C., Neureiter, D., Schuppan, D., & Rosenberg, W. M. (2017). Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , 29(3), 289-296. https://doi.org/10.1097/MEG.0000000000000789

Tanwar, Sudeep ; Trembling, Paul M ; Hogan, Brian J et al. / Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. In: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 2017 ; Vol. 29, No. 3. pp. 289-296.

@article{29699519d1434a3da1714927472f2f59,

title = "Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.",

keywords = "CHRONIC HEPATITIS-C, VALIDATED PREDICTOR, UNITED-STATES, INFECTION, TESTS, ELASTOGRAPHY, CIRRHOSIS, ACCURACY, BIOPSY",

author = "Sudeep Tanwar and Trembling, \{Paul M\} and Hogan, \{Brian J\} and Ankur Srivastava and Julie Parkes and Scott Harris and Paul Grant and Eleni Nastouli and Mathias Ocker and Klaus Wehr and Christoph Herold and Daniel Neureiter and Detlef Schuppan and Rosenberg, \{William M\}",

note = "Neureiter: Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria",

year = "2017",

doi = "10.1097/MEG.0000000000000789",

language = "English",

volume = "29",

pages = "289--296",

journal = "EUROPEAN JOURNAL OF GASTROENTEROLOGY \& HEPATOLOGY ",

issn = "0954-691X",

number = "3",

}

Tanwar, S, Trembling, PM, Hogan, BJ, Srivastava, A, Parkes, J, Harris, S, Grant, P, Nastouli, E, Ocker, M, Wehr, K, Herold, C, Neureiter, D, Schuppan, D & Rosenberg, WM 2017, 'Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.', EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol. 29, no. 3, pp. 289-296. https://doi.org/10.1097/MEG.0000000000000789

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. / Tanwar, Sudeep; Trembling, Paul M; Hogan, Brian J et al.
In: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , Vol. 29, No. 3, 2017, p. 289-296.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

AU - Tanwar, Sudeep

AU - Trembling, Paul M

AU - Hogan, Brian J

AU - Srivastava, Ankur

AU - Parkes, Julie

AU - Harris, Scott

AU - Grant, Paul

AU - Nastouli, Eleni

AU - Ocker, Mathias

AU - Wehr, Klaus

AU - Herold, Christoph

AU - Neureiter, Daniel

AU - Schuppan, Detlef

AU - Rosenberg, William M

N1 - Neureiter: Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria

PY - 2017

Y1 - 2017

KW - CHRONIC HEPATITIS-C

KW - VALIDATED PREDICTOR

KW - UNITED-STATES

KW - INFECTION

KW - TESTS

KW - ELASTOGRAPHY

KW - CIRRHOSIS

KW - ACCURACY

KW - BIOPSY

U2 - 10.1097/MEG.0000000000000789

DO - 10.1097/MEG.0000000000000789

M3 - Original Article

C2 - 27906753

SN - 0954-691X

VL - 29

SP - 289

EP - 296

JO - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

JF - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

IS - 3

ER -

Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S et al. Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY . 2017;29(3):289-296. doi: 10.1097/MEG.0000000000000789